VectorBuilder
Business Services · Illinois, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Vectorbuilder Inc. 1010 W 35th St Ste 51...Phone Number
(408) 969-0306Website
www.vectorbuilder.comRevenue
$16.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About VectorBuilder
VectorBuilder is a global leader in gene delivery technologies, providing a comprehensive range of solutions for research and clinical applications. Their services include vector design, cloning, viral vector manufacturing, and therapeutic RNA development, catering to biotech and pharmaceutical companies worldwide. With a focus on innovation and scalability, VectorBuilder supports thousands of labs in their gene delivery needs from bench to bedside. Their user-friendly platform and expert support make them a trusted partner in advancing molecular biology research.Explore more
VectorBuilder Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VectorBuilder your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if VectorBuilder is spiking on competitors!
VectorBuilder, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on VectorBuilder recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at VectorBuilder
Check if VectorBuilder has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once VectorBuilder has new funding data
Product Launch: Get notified when VectorBuilder launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if VectorBuilder had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at VectorBuilder
Find 3 more new buyers
Compare Similar Companies to VectorBuilder
Compare insights from companies similar to VectorBuilder, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
VectorBuilder
$16.4M
51-200
Private
$56M
2015
MM
Miho MatakatsuManaging Director, Vectorbuilder , Inc (Japan)
Company Profile Activity
Activity Insights
VectorBuilder is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
VectorBuilder is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about VectorBuilder.
VectorBuilder financials insights
Gather financial insights about VectorBuilder, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series C
$56M
VectorBuilder Tech Stack
A closer look at the technologies used by VectorBuilder
Most Recent Scoops
Hiring Plans
VectorBuilder has more open roles in Marketing than it has had at any time in the past 12 months. Technologies mentioned include: Retargeting. Areas of expertise include: Content Marketing, Digital Marketing, Campaign Performance Analysis, Marketing Strategies, Campaign Management, Multi-Channel Marketing, and Marketing Automation.
Hiring Plans
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Facilities Relocation / Expansion
Facilities Management
Open Position
Funding
VectorBuilder News & Media
Nobel-Potential Discovery from VectorBuilder Scientists Reveals Fundamental Mechanisms of Development
Dr. Bruce Lahn’s team at VectorBuilder developed Potency-Seq, revealing how genes lose activation potential during cell differentiation.VectorBuilder Powers FDA IND Approval of World’s First Umbilical Cord Blood-Derived Allogeneic CAR-T Product
CHICAGO--(BUSINESS WIRE)-- #BioTechNews--VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy, UC101, received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) on January 11, 2025. VectorBuilder has provided highly customized end-to-end CDMO solutions to support this clinical pipeline. Dr. Bruce Lahn, Chief Scientist at VectorBuilder, commented, "Congratulations to Chengdu Ucello on tGenetic Immunity (GI) Leverages VectorBuilder Partnership to Power Phase 3 HIV Vaccine Trials
CHICAGO--(BUSINESS WIRE)-- #BioTechNews--Genetic Immunity, a leader in plasmid DNA-based immunotherapies, and VectorBuilder, a global specialist in gene delivery solutions, announced a strategic partnership to advance Genetic Immunity's innovative HIV vaccine into a late-stage clinical trial. Renowned for its focus on developing cutting-edge DNA-based vaccines, Genetic Immunity has built an industry-leading team to deliver its lead candidate, a plasmid DNA HIV vaccine, into a Phase 3 trial. TheVectorBuilder and Sartorius Sign Strategic Cooperation Agreement to Advance Biopharmaceutical Innovation
GUANGZHOU, China, Nov. 26, 2024 /PRNewswire/ -- VectorBuilder, a global leader in end-to-end gene delivery services, and Sartorius, a leading international partner in life science research and the biopharmaceutical industry, recently announced a strategic cooperation agreement. The collaboration will focus on gene vector and mRNA bioprocess solutions and services, accelerating the development and clinical translation of innovative biopharmaceutical projects. Building on years of successful colla
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VectorBuilder
Sign Up For FreeTo access detailed company insights
VectorBuilder is a global leader in gene delivery technologies, providing a comprehensive range of solutions for research and clinical applications. Their services include vector design, cloning, viral vector manufacturing, and therapeutic RNA development, catering to biotech and pharmaceutical companies worldwide. With a focus on innovation and sc... Read More
